The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(6-Chloro-8-(((2-ethylpyridin-4-yl)methyl)amino)-2-methylimidazo[1,2-b]pyridazin-3-yl)-N-(2-hydroxyethyl)-2-methoxybenzenesulfonamide ID: ALA3976651
PubChem CID: 134151667
Max Phase: Preclinical
Molecular Formula: C24H27ClN6O4S
Molecular Weight: 531.04
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cc(CNc2cc(Cl)nn3c(-c4ccc(OC)c(S(=O)(=O)NCCO)c4)c(C)nc23)ccn1
Standard InChI: InChI=1S/C24H27ClN6O4S/c1-4-18-11-16(7-8-26-18)14-27-19-13-22(25)30-31-23(15(2)29-24(19)31)17-5-6-20(35-3)21(12-17)36(33,34)28-9-10-32/h5-8,11-13,27-28,32H,4,9-10,14H2,1-3H3
Standard InChI Key: IUFHKDJSTXKARD-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
6.0959 -14.2513 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8854 -15.0437 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.6769 -14.8298 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0886 -14.8802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5449 -15.4904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7412 -15.3210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4854 -14.5455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0291 -13.9353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8328 -14.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2886 -15.7571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8007 -16.2659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2570 -16.8761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1059 -15.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5056 -16.4765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3229 -16.4830 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9929 -12.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2852 -11.6894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5789 -12.1028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5803 -12.9200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2922 -13.3238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9985 -12.9104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7684 -11.8374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2531 -12.4974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7733 -13.1598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0702 -12.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2797 -10.8723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5719 -10.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2671 -8.4207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2727 -9.2379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5664 -9.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8587 -9.2434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8531 -8.4262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5594 -8.0128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9734 -8.0073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9720 -7.1902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8782 -13.3293 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
2 10 1 0
4 2 1 0
11 12 1 0
5 11 1 0
13 14 1 0
14 15 1 0
10 13 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 1 0
22 23 1 0
23 24 2 0
21 24 1 0
16 22 2 0
23 25 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
28 33 2 0
34 35 1 0
28 34 1 0
27 30 1 0
26 27 1 0
17 26 1 0
19 36 1 0
8 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 531.04Molecular Weight (Monoisotopic): 530.1503AlogP: 3.21#Rotatable Bonds: 10Polar Surface Area: 130.74Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.48CX Basic pKa: 5.55CX LogP: 1.97CX LogD: 1.96Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.28Np Likeness Score: -1.41
References 1. Mejdrová I, Chalupská D, Plačková P, Müller C, Šála M, Klíma M, Baumlová A, Hřebabecký H, Procházková E, Dejmek M, Strunin D, Weber J, Lee G, Matoušová M, Mertlíková-Kaiserová H, Ziebuhr J, Birkus G, Boura E, Nencka R.. (2017) Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology., 60 (1): [PMID:28004945 ] [10.1021/acs.jmedchem.6b01465 ]